4//SEC Filing
Chaves Allen 4
Accession 0001835830-24-000095
CIK 0001835830other
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 5:41 PM ET
Size
19.8 KB
Accession
0001835830-24-000095
Insider Transaction Report
Form 4
Klaviyo, Inc.KVYO
Chaves Allen
Chief Technology Officer
Transactions
- Conversion
Series A Common Stock
2024-09-16+130,000→ 130,000 total - Exercise/Conversion
Series B Common Stock
2024-09-16+130,000→ 356,314 total→ Series A Common Stock (130,000 underlying) - Exercise/Conversion
Series B Common Stock
2024-09-17+32,733→ 259,047 total→ Series A Common Stock (32,733 underlying) - Sale
Series A Common Stock
2024-09-16$32.03/sh−101,066$3,237,144→ 28,934 total - Sale
Series A Common Stock
2024-09-16$31.21/sh−28,934$903,030→ 0 total - Conversion
Series B Common Stock
2024-09-16−130,000→ 226,314 total→ Series A Common Stock (130,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-09-16−130,000→ 1,028,693 totalExercise: $3.06Exp: 2030-04-15→ Series B Common Stock (130,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-09-17−32,733→ 995,960 totalExercise: $3.06Exp: 2030-04-15→ Series B Common Stock (32,733 underlying)
Footnotes (6)
- [F1]These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 21, 2023.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.50 to $32.50 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.65 to $31.49 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The shares underlying this option are fully vested and exercisable by the Reporting Person as of the date hereof.
- [F5]Each share of Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), of the Issuer, and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date.
- [F6]Consists of (i) 178,203 shares of Series B Common Stock and (ii) 80,844 unvested restricted stock units awarded under the Issuer's 2015 Stock Incentive Plan, each representing the contingent right to receive one share of Series B Common Stock upon vesting and settlement.
Documents
Issuer
Klaviyo, Inc.
CIK 0001835830
Entity typeother
Related Parties
1- filerCIK 0001991400
Filing Metadata
- Form type
- 4
- Filed
- Sep 17, 8:00 PM ET
- Accepted
- Sep 18, 5:41 PM ET
- Size
- 19.8 KB